Oct. 4, 2013
/PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 12th Annual BIO Investor Forum on
Tuesday, October 8, 2013
3:30 p.m. Pacific Time
. Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual BIO Investor Forum will take place
at The Palace Hotel in
, Ph.D., President and Chief Executive Officer of Palatin Technologies, will provide an update on Palatin's corporate and development programs.
About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin's website at
SOURCE Palatin Technologies, Inc.